Anti-a antibodies and bacterial contamination of platelet concentrates;Anticuerpos anti-a y contaminación bacteriana de los concentrados de plaquetas

Sangre

Volumn 44, Issue 6, 1999, Pages 434-437

  García Erce, José Antonio ^a   Seoane, Antonio ^b   Solano, Víctor M ^b   Osuna, Carlos Salvador ^b   Pérez Layo, Angeles ^b   Gómez Arteta, Emilio ^b   Gimeno, Juan J ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COAGULASE;

ARTICLE; BLOOD GROUP ABO SYSTEM; HUMAN; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; MICROBIOLOGY; SERUM BACTERICIDAL ACTIVITY; THROMBOCYTE;

ABO BLOOD-GROUP SYSTEM; BLOOD BACTERICIDAL ACTIVITY; BLOOD PLATELETS; COAGULASE; HUMANS;

EID: 0033291569     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Salmon Ch, Cartrou IP, Rouger Ph. Groupes sanguins et maladies. Salmon Ch, Cartrou JP, Rouger Ph, Eds. Groupes sanguins et maladies, 2nd ed. Paris: Masson; 1991: 425-433.
2. Barbolla L. Significado clínico del sistema ABO. Sangre 1995 (supl.2); 40:9-13.
3. Hogman CF. Adverse effects: bacterial contamination (including shelf life). A brief review of bacterial contamination of blood components. Vox Sang 1996; 70 (supl. 3):78-82.
4. Barrett BB, Andersen JW, Andersen KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion 1993; 33: 228-233.
5. Yomtovian R, Lazarus HM, Goodnough LT. et al. A prospective microbiologic surveillance program to detect and prevent the transfusion of bacterially contaminated platelets. Transfusion 1993; 33: 902-909.
6. Chin EK, Yuen KY, Lie AK, Liang R, Lau YL. A prospective study of symptomatic bacteriemia following platelet transfusion and of its management. Transfusion 1994; 34: 950-954.
7. Klein HG, Dodd RY, Ness PM, Fratantoni JA, Nemo GJ. Current status of microbial contamination of blood components: summary of a conference. Transfusion 1997; 37: 95-101.
8. Zaza S, Tokars JI, Yomtovian R, Hirschler NV, Jacobs MR, Lazarus HM, et al. Bacterial contamination of platelets at a university hospital: increased identification due to intensified surveillance. Infect Control Hosp Epidemiol 1994; 15: 82-87.
9. Heddle NM, Klama LN, Griffith L, Robertsd R, Shukla G, Kelton JG. A prospective study to identify the risk factors associated with a acute reactions to platelet and red cell transfusions. Transfusion 1993; 33: 794-797.
10. Soeterboek AM, Welle FHW, Marcelis JH, van der Loop CMF. Sterility testing of blood products in 1994/1995 by three cooperating blood banks in the Netherlands. Vox Sang 1997; 72:61-62.
11. Araújo F, Alves V, Oliveira G, Fonseca C, Araújo AR. Contaminación bacteriana de los concentrados de plaquetas. Sangre 1997; 42: 483-484.
12. Leiby DA, Kerr KL, Campos JM, Dodd RY. A retrospective analysis of microbial contaminants in outdated random-donor platelets from multiple sites. Transfusion 1997; 37: 259-263.
13. García-Erce JA, Gimenc JJ, Marco ML, Solano VM, Gómez-Arteta E, Scoane A et al. Control bacteriológico de los concentrados de plaquetas. Sangre 1997; 42 (Suppl 2): 115.
14. Argimón JM, Jiménez J. Tamaño de la muestra, Métodos de investigación aplicados a la atención primaria de salud. Ed. Doyma. Barcelona 1991; 77-89.
15. th ed. Arlington (Virgina): American Association of Blood Banks; 1990.
16. Dave J, Brett M, MacLennan S, Shields M. Sepsis associated with blood transfusion. Lancet 1996; 347:1773.
17. Olsen KE., Sandler SG. Febrile neutropenia contributes to underreporting of potencial septic platelet transfusion reactions. Vox Sang 1996; 70: 118.
18. Dauda RK, Collins KA, Kitchens CS. Case report: Fatal Staphylococcus aureus sepsis from single-donor platelet transfusion. Am J Med Sci 1994; 307: 340
19. Cid J, Lozano B, Nomdedeu B, Mazzarra R, Vila J, Rives S, Ordinas A. Sepsis estafilocócica asociada a transfusion de plaquetas: Aportación de un nuevo caso y revisión de la literatura. Sangre 1997; 42: 407-409.
20. Mollison PL, Engelfriet CP, Contreras M. Blood transfusion in clinical medicine, 9th ed. London: Blackwell Scientific Publications; 1993.
21. Sachs V. ABO blood groups and Escherichia Coli sepsis. Transfusion 1987; 27: 504-507.
22. Schaffner. Skin antisepsis at donor site: is there room for improvement (Editorial). Transfusion 1997; 37: 249-250.
23. Follea G, Saint-Laurent P, Bigey F, Gayet S, Bientz M, Cazenave JP. Evaluation bactériologique quantitative d'une méthode de désinfection cutanée chez les donneurs de sang. Transfus Clin Biol 1997; 523-531.
24. Olthuis H, Puylaert C, Verhagen C, Valk L: A simple method to remove contaminating during venopuncture. Vox Sang 1996; 70(supl. 2): 113.
25. Girard A [Leukocyte depletion of blood products and post-transfusion infections] Deleucocytation des produits sanguins et infections post-transfusionnelles. Rev Fr Transfus Hemobiol 1993; 36: 265-279.
26. Sanz C, Faúndez A, Vila J, Pereira A, Ordinas A. Importancia de los leucocitos en el retraso del crecimiento bacteriano durante la conservación de la sangre total en placas de butanadiol. Sangre 1995; 40 (supl.4):17.
27. Sanz C, Pereira A, Vila J, Faundez Al, Gomez J, Ordinas A. Growth of bacteria in platelet concentrates obtained from whole blod stored for 16 hours at 22°C before component preparation. Transfusion 1997; 37: 251-254.
28. Burstain JM, Brecher ME, Workman K, Foster M, Faber GH, Mair D. Rapid identification of bacterially contaminated platelet using reagent strips: glucose an pH analysis as markers of bacterial metabolims. Transfusion 1997; 37: 255-258.